BindingDB logo
myBDB logout

Patent code US9790180

Compile Data Set for Download or QSAR
Found 126 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347485
PNG
(US9790180, ID 019 | US9790180, ID 020)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCOCC2)cc1)-c1cccs1
Show InChI InChI=1S/C27H31N5O3S/c28-23-8-5-20(25-2-1-17-36-25)18-24(23)30-26(33)19-3-6-21(7-4-19)29-22-9-11-31(12-10-22)27(34)32-13-15-35-16-14-32/h1-8,17-18,22,29H,9-16,28H2,(H,30,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 0.900n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347471
PNG
(US9790180, ID 005)
Show SMILES CN1CCN(CC1)C(=O)N1CCC(CC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C28H34N6O2S/c1-32-14-16-34(17-15-32)28(36)33-12-10-23(11-13-33)30-22-7-4-20(5-8-22)27(35)31-25-19-21(6-9-24(25)29)26-3-2-18-37-26/h2-9,18-19,23,30H,10-17,29H2,1H3,(H,31,35)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.20n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347468
PNG
(US9790180, ID 004)
Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C28H33N5O3S/c1-28(10-12-32(13-11-28)27(35)33-14-16-36-17-15-33)31-22-7-4-20(5-8-22)26(34)30-24-19-21(6-9-23(24)29)25-3-2-18-37-25/h2-9,18-19,31H,10-17,29H2,1H3,(H,30,34)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 2n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347481
PNG
(US9790180, ID 015)
Show SMILES CC1(CCN(CC1)C(=O)N1CCNCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C28H34N6O2S/c1-28(10-14-33(15-11-28)27(36)34-16-12-30-13-17-34)32-22-7-4-20(5-8-22)26(35)31-24-19-21(6-9-23(24)29)25-3-2-18-37-25/h2-9,18-19,30,32H,10-17,29H2,1H3,(H,31,35)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 3.20n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347482
PNG
(US9790180, ID 016)
Show SMILES CN1CCN(CC1)C(=O)N1CCC(C)(CC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C29H36N6O2S/c1-29(11-13-34(14-12-29)28(37)35-17-15-33(2)16-18-35)32-23-8-5-21(6-9-23)27(36)31-25-20-22(7-10-24(25)30)26-4-3-19-38-26/h3-10,19-20,32H,11-18,30H2,1-2H3,(H,31,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 3.20n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347485
PNG
(US9790180, ID 019 | US9790180, ID 020)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCOCC2)cc1)-c1cccs1
Show InChI InChI=1S/C27H31N5O3S/c28-23-8-5-20(25-2-1-17-36-25)18-24(23)30-26(33)19-3-6-21(7-4-19)29-22-9-11-31(12-10-22)27(34)32-13-15-35-16-14-32/h1-8,17-18,22,29H,9-16,28H2,(H,30,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 3.70n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347490
PNG
(US9790180, ID 023)
Show SMILES CCC1(CCN(CC1)C(=O)N1CCNCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C29H36N6O2S/c1-2-29(11-15-34(16-12-29)28(37)35-17-13-31-14-18-35)33-23-8-5-21(6-9-23)27(36)32-25-20-22(7-10-24(25)30)26-4-3-19-38-26/h3-10,19-20,31,33H,2,11-18,30H2,1H3,(H,32,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 3.90n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347479
PNG
(US9790180, ID 013)
Show SMILES CC1(CCN(CC1)C(=O)N1CCCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C28H33N5O2S/c1-28(12-16-33(17-13-28)27(35)32-14-2-3-15-32)31-22-9-6-20(7-10-22)26(34)30-24-19-21(8-11-23(24)29)25-5-4-18-36-25/h4-11,18-19,31H,2-3,12-17,29H2,1H3,(H,30,34)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 4n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347485
PNG
(US9790180, ID 019 | US9790180, ID 020)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCOCC2)cc1)-c1cccs1
Show InChI InChI=1S/C27H31N5O3S/c28-23-8-5-20(25-2-1-17-36-25)18-24(23)30-26(33)19-3-6-21(7-4-19)29-22-9-11-31(12-10-22)27(34)32-13-15-35-16-14-32/h1-8,17-18,22,29H,9-16,28H2,(H,30,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 4.20n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347472
PNG
(US9790180, ID 006)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCCC2)cc1)-c1cccs1
Show InChI InChI=1S/C27H31N5O2S/c28-23-10-7-20(25-4-3-17-35-25)18-24(23)30-26(33)19-5-8-21(9-6-19)29-22-11-15-32(16-12-22)27(34)31-13-1-2-14-31/h3-10,17-18,22,29H,1-2,11-16,28H2,(H,30,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 4.70n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347471
PNG
(US9790180, ID 005)
Show SMILES CN1CCN(CC1)C(=O)N1CCC(CC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C28H34N6O2S/c1-32-14-16-34(17-15-32)28(36)33-12-10-23(11-13-33)30-22-7-4-20(5-8-22)27(35)31-25-19-21(6-9-24(25)29)26-3-2-18-37-26/h2-9,18-19,23,30H,10-17,29H2,1H3,(H,31,35)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 4.90n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347489
PNG
(US9790180, ID 022)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2CCOCC2)cc1)-c1cccs1
Show InChI InChI=1S/C28H32N4O3S/c29-24-8-5-21(26-2-1-17-36-26)18-25(24)31-27(33)19-3-6-22(7-4-19)30-23-9-13-32(14-10-23)28(34)20-11-15-35-16-12-20/h1-8,17-18,20,23,30H,9-16,29H2,(H,31,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 5n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347491
PNG
(US9790180, ID 024)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2(O)CCCCC2)cc1)-c1cccs1
Show InChI InChI=1S/C29H34N4O3S/c30-24-11-8-21(26-5-4-18-37-26)19-25(24)32-27(34)20-6-9-22(10-7-20)31-23-12-16-33(17-13-23)28(35)29(36)14-2-1-3-15-29/h4-11,18-19,23,31,36H,1-3,12-17,30H2,(H,32,34)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 6n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347455
PNG
(US9790180, ID 001)
Show SMILES CC(C)NC(=O)N1CCC(C)(CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C25H31N7O2S/c1-16(2)29-24(34)32-10-8-25(3,9-11-32)31-23-27-14-18(15-28-23)22(33)30-20-13-17(6-7-19(20)26)21-5-4-12-35-21/h4-7,12-16H,8-11,26H2,1-3H3,(H,29,34)(H,30,33)(H,27,28,31)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 6.5n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347492
PNG
(US9790180, ID 025)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2(O)CCCC2)cc1)-c1cccs1
Show InChI InChI=1S/C28H32N4O3S/c29-23-10-7-20(25-4-3-17-36-25)18-24(23)31-26(33)19-5-8-21(9-6-19)30-22-11-15-32(16-12-22)27(34)28(35)13-1-2-14-28/h3-10,17-18,22,30,35H,1-2,11-16,29H2,(H,31,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 7n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347459
PNG
(US9790180, ID 002)
Show SMILES CC(C)C1(CCN(CC1)C(=O)N1CCN(C)CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C29H38N8O2S/c1-20(2)29(8-10-36(11-9-29)28(39)37-14-12-35(3)13-15-37)34-27-31-18-22(19-32-27)26(38)33-24-17-21(6-7-23(24)30)25-5-4-16-40-25/h4-7,16-20H,8-15,30H2,1-3H3,(H,33,38)(H,31,32,34)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 7n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347497
PNG
(US9790180, ID 030)
Show SMILES CC1(CCN(CC1)C(=O)N1CCCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1ccncc1
Show InChI InChI=1S/C29H34N6O2/c1-29(12-18-35(19-13-29)28(37)34-16-2-3-17-34)33-24-7-4-22(5-8-24)27(36)32-26-20-23(6-9-25(26)30)21-10-14-31-15-11-21/h4-11,14-15,20,33H,2-3,12-13,16-19,30H2,1H3,(H,32,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 7.10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347476
PNG
(US9790180, ID 010)
Show SMILES CC1(CCN(CC1)C(=O)N1CCNCC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C26H32N8O2S/c1-26(6-10-33(11-7-26)25(36)34-12-8-28-9-13-34)32-24-29-16-19(17-30-24)23(35)31-21-15-18(4-5-20(21)27)22-3-2-14-37-22/h2-5,14-17,28H,6-13,27H2,1H3,(H,31,35)(H,29,30,32)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 7.30n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347508
PNG
(US9790180, ID 040)
Show SMILES CN1CCC(CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C23H26N6O/c1-29-11-9-19(10-12-29)27-23-25-14-18(15-26-23)22(30)28-21-13-17(7-8-20(21)24)16-5-3-2-4-6-16/h2-8,13-15,19H,9-12,24H2,1H3,(H,28,30)(H,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 8n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347477
PNG
(US9790180, ID 011)
Show SMILES CN1CCN(CC1)C(=O)N1CCC(C)(CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C27H34N8O2S/c1-27(7-9-34(10-8-27)26(37)35-13-11-33(2)12-14-35)32-25-29-17-20(18-30-25)24(36)31-22-16-19(5-6-21(22)28)23-4-3-15-38-23/h3-6,15-18H,7-14,28H2,1-2H3,(H,31,36)(H,29,30,32)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 8.5n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347474
PNG
(US9790180, ID 008)
Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C26H31N7O3S/c1-26(6-8-32(9-7-26)25(35)33-10-12-36-13-11-33)31-24-28-16-19(17-29-24)23(34)30-21-15-18(4-5-20(21)27)22-3-2-14-37-22/h2-5,14-17H,6-13,27H2,1H3,(H,30,34)(H,28,29,31)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 9n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347497
PNG
(US9790180, ID 030)
Show SMILES CC1(CCN(CC1)C(=O)N1CCCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1ccncc1
Show InChI InChI=1S/C29H34N6O2/c1-29(12-18-35(19-13-29)28(37)34-16-2-3-17-34)33-24-7-4-22(5-8-24)27(36)32-26-20-23(6-9-25(26)30)21-10-14-31-15-11-21/h4-11,14-15,20,33H,2-3,12-13,16-19,30H2,1H3,(H,32,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 9.40n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347493
PNG
(US9790180, ID 026)
Show SMILES CN1CCC(CC1)(Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1)c1ccccc1
Show InChI InChI=1S/C27H28N6OS/c1-33-13-11-27(12-14-33,21-6-3-2-4-7-21)32-26-29-17-20(18-30-26)25(34)31-23-16-19(9-10-22(23)28)24-8-5-15-35-24/h2-10,15-18H,11-14,28H2,1H3,(H,31,34)(H,29,30,32)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347481
PNG
(US9790180, ID 015)
Show SMILES CC1(CCN(CC1)C(=O)N1CCNCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C28H34N6O2S/c1-28(10-14-33(15-11-28)27(36)34-16-12-30-13-17-34)32-22-7-4-20(5-8-22)26(35)31-24-19-21(6-9-23(24)29)25-3-2-18-37-25/h2-9,18-19,30,32H,10-17,29H2,1H3,(H,31,35)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 12n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347484
PNG
(US9790180, ID 018)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(nc1)N1CCCC11CCN(CC1)C(=O)N1CCCC1)-c1cccs1
Show InChI InChI=1S/C28H33N7O2S/c29-22-7-6-20(24-5-3-16-38-24)17-23(22)32-25(36)21-18-30-26(31-19-21)35-13-4-8-28(35)9-14-34(15-10-28)27(37)33-11-1-2-12-33/h3,5-7,16-19H,1-2,4,8-15,29H2,(H,32,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 12n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347496
PNG
(US9790180, ID 029)
Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1ccncc1
Show InChI InChI=1S/C29H34N6O3/c1-29(10-14-34(15-11-29)28(37)35-16-18-38-19-17-35)33-24-5-2-22(3-6-24)27(36)32-26-20-23(4-7-25(26)30)21-8-12-31-13-9-21/h2-9,12-13,20,33H,10-11,14-19,30H2,1H3,(H,32,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 12n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347482
PNG
(US9790180, ID 016)
Show SMILES CN1CCN(CC1)C(=O)N1CCC(C)(CC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C29H36N6O2S/c1-29(11-13-34(14-12-29)28(37)35-17-15-33(2)16-18-35)32-23-8-5-21(6-9-23)27(36)31-25-20-22(7-10-24(25)30)26-4-3-19-38-26/h3-10,19-20,32H,11-18,30H2,1-2H3,(H,31,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 13n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347479
PNG
(US9790180, ID 013)
Show SMILES CC1(CCN(CC1)C(=O)N1CCCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C28H33N5O2S/c1-28(12-16-33(17-13-28)27(35)32-14-2-3-15-32)31-22-9-6-20(7-10-22)26(34)30-24-19-21(8-11-23(24)29)25-5-4-18-36-25/h4-11,18-19,31H,2-3,12-17,29H2,1H3,(H,30,34)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 14n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347509
PNG
(US9790180, ID 041)
Show SMILES CC1(CCNCC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C23H26N6O/c1-23(9-11-25-12-10-23)29-22-26-14-18(15-27-22)21(30)28-20-13-17(7-8-19(20)24)16-5-3-2-4-6-16/h2-8,13-15,25H,9-12,24H2,1H3,(H,28,30)(H,26,27,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 14n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347488
PNG
(US9790180, ID 021)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2CCCCC2)cc1)-c1cccs1
Show InChI InChI=1S/C29H34N4O2S/c30-25-13-10-22(27-7-4-18-36-27)19-26(25)32-28(34)20-8-11-23(12-9-20)31-24-14-16-33(17-15-24)29(35)21-5-2-1-3-6-21/h4,7-13,18-19,21,24,31H,1-3,5-6,14-17,30H2,(H,32,34)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 15n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347467
PNG
(US9790180, ID 003)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)C(=O)N2CCOCC2)nc1)-c1cccs1
Show InChI InChI=1S/C25H29N7O3S/c26-20-4-3-17(22-2-1-13-36-22)14-21(20)30-23(33)18-15-27-24(28-16-18)29-19-5-7-31(8-6-19)25(34)32-9-11-35-12-10-32/h1-4,13-16,19H,5-12,26H2,(H,30,33)(H,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 15n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347496
PNG
(US9790180, ID 029)
Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1ccncc1
Show InChI InChI=1S/C29H34N6O3/c1-29(10-14-34(15-11-29)28(37)35-16-18-38-19-17-35)33-24-5-2-22(3-6-24)27(36)32-26-20-23(4-7-25(26)30)21-8-12-31-13-9-21/h2-9,12-13,20,33H,10-11,14-19,30H2,1H3,(H,32,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 17n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347507
PNG
(US9790180, ID 039)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCNCC2)nc1)-c1ccccc1
Show InChI InChI=1S/C22H24N6O/c23-19-7-6-16(15-4-2-1-3-5-15)12-20(19)28-21(29)17-13-25-22(26-14-17)27-18-8-10-24-11-9-18/h1-7,12-14,18,24H,8-11,23H2,(H,28,29)(H,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 17n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347485
PNG
(US9790180, ID 019 | US9790180, ID 020)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCOCC2)cc1)-c1cccs1
Show InChI InChI=1S/C27H31N5O3S/c28-23-8-5-20(25-2-1-17-36-25)18-24(23)30-26(33)19-3-6-21(7-4-19)29-22-9-11-31(12-10-22)27(34)32-13-15-35-16-14-32/h1-8,17-18,22,29H,9-16,28H2,(H,30,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 17n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347500
PNG
(US9790180, ID 032)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCCC2)cc1)-c1ccncc1
Show InChI InChI=1S/C28H32N6O2/c29-25-8-5-22(20-9-13-30-14-10-20)19-26(25)32-27(35)21-3-6-23(7-4-21)31-24-11-17-34(18-12-24)28(36)33-15-1-2-16-33/h3-10,13-14,19,24,31H,1-2,11-12,15-18,29H2,(H,32,35)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 17n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347489
PNG
(US9790180, ID 022)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2CCOCC2)cc1)-c1cccs1
Show InChI InChI=1S/C28H32N4O3S/c29-24-8-5-21(26-2-1-17-36-26)18-25(24)31-27(33)19-3-6-22(7-4-19)30-23-9-13-32(14-10-23)28(34)20-11-15-35-16-12-20/h1-8,17-18,20,23,30H,9-16,29H2,(H,31,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 18n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347483
PNG
(US9790180, ID 017)
Show SMILES CCC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C29H35N5O3S/c1-2-29(11-13-33(14-12-29)28(36)34-15-17-37-18-16-34)32-23-8-5-21(6-9-23)27(35)31-25-20-22(7-10-24(25)30)26-4-3-19-38-26/h3-10,19-20,32H,2,11-18,30H2,1H3,(H,31,35)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 18n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347478
PNG
(US9790180, ID 012)
Show SMILES CC1(CCN(CC1)C(=O)N1CCC(F)(F)CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C27H31F2N7O2S/c1-26(6-10-35(11-7-26)25(38)36-12-8-27(28,29)9-13-36)34-24-31-16-19(17-32-24)23(37)33-21-15-18(4-5-20(21)30)22-3-2-14-39-22/h2-5,14-17H,6-13,30H2,1H3,(H,33,37)(H,31,32,34)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 19n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347500
PNG
(US9790180, ID 032)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCCC2)cc1)-c1ccncc1
Show InChI InChI=1S/C28H32N6O2/c29-25-8-5-22(20-9-13-30-14-10-20)19-26(25)32-27(35)21-3-6-23(7-4-21)31-24-11-17-34(18-12-24)28(36)33-15-1-2-16-33/h3-10,13-14,19,24,31H,1-2,11-12,15-18,29H2,(H,32,35)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 20n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347490
PNG
(US9790180, ID 023)
Show SMILES CCC1(CCN(CC1)C(=O)N1CCNCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C29H36N6O2S/c1-2-29(11-15-34(16-12-29)28(37)35-17-13-31-14-18-35)33-23-8-5-21(6-9-23)27(36)32-25-20-22(7-10-24(25)30)26-4-3-19-38-26/h3-10,19-20,31,33H,2,11-18,30H2,1H3,(H,32,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 20n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347468
PNG
(US9790180, ID 004)
Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C28H33N5O3S/c1-28(10-12-32(13-11-28)27(35)33-14-16-36-17-15-33)31-22-7-4-20(5-8-22)26(34)30-24-19-21(6-9-23(24)29)25-3-2-18-37-25/h2-9,18-19,31H,10-17,29H2,1H3,(H,30,34)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 21n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347472
PNG
(US9790180, ID 006)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCCC2)cc1)-c1cccs1
Show InChI InChI=1S/C27H31N5O2S/c28-23-10-7-20(25-4-3-17-35-25)18-24(23)30-26(33)19-5-8-21(9-6-19)29-22-11-15-32(16-12-22)27(34)31-13-1-2-14-31/h3-10,17-18,22,29H,1-2,11-16,28H2,(H,30,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 22n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347503
PNG
(US9790180, ID 035)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)C(=O)Cc2c[nH]c3ccccc23)nc1)-c1ccccc1
Show InChI InChI=1S/C32H31N7O2/c33-27-11-10-22(21-6-2-1-3-7-21)16-29(27)38-31(41)24-19-35-32(36-20-24)37-25-12-14-39(15-13-25)30(40)17-23-18-34-28-9-5-4-8-26(23)28/h1-11,16,18-20,25,34H,12-15,17,33H2,(H,38,41)(H,35,36,37)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 22n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347492
PNG
(US9790180, ID 025)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2(O)CCCC2)cc1)-c1cccs1
Show InChI InChI=1S/C28H32N4O3S/c29-23-10-7-20(25-4-3-17-36-25)18-24(23)31-26(33)19-5-8-21(9-6-19)30-22-11-15-32(16-12-22)27(34)28(35)13-1-2-14-28/h3-10,17-18,22,30,35H,1-2,11-16,29H2,(H,31,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 26n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347509
PNG
(US9790180, ID 041)
Show SMILES CC1(CCNCC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C23H26N6O/c1-23(9-11-25-12-10-23)29-22-26-14-18(15-27-22)21(30)28-20-13-17(7-8-19(20)24)16-5-3-2-4-6-16/h2-8,13-15,25H,9-12,24H2,1H3,(H,28,30)(H,26,27,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 26n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347476
PNG
(US9790180, ID 010)
Show SMILES CC1(CCN(CC1)C(=O)N1CCNCC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C26H32N8O2S/c1-26(6-10-33(11-7-26)25(36)34-12-8-28-9-13-34)32-24-29-16-19(17-30-24)23(35)31-21-15-18(4-5-20(21)27)22-3-2-14-37-22/h2-5,14-17,28H,6-13,27H2,1H3,(H,31,35)(H,29,30,32)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 26n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347491
PNG
(US9790180, ID 024)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2(O)CCCCC2)cc1)-c1cccs1
Show InChI InChI=1S/C29H34N4O3S/c30-24-11-8-21(26-5-4-18-37-26)19-25(24)32-27(34)20-6-9-22(10-7-20)31-23-12-16-33(17-13-23)28(35)29(36)14-2-1-3-15-29/h4-11,18-19,23,31,36H,1-3,12-17,30H2,(H,32,34)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 26n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347459
PNG
(US9790180, ID 002)
Show SMILES CC(C)C1(CCN(CC1)C(=O)N1CCN(C)CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C29H38N8O2S/c1-20(2)29(8-10-36(11-9-29)28(39)37-14-12-35(3)13-15-37)34-27-31-18-22(19-32-27)26(38)33-24-17-21(6-7-23(24)30)25-5-4-16-40-25/h4-7,16-20H,8-15,30H2,1-3H3,(H,33,38)(H,31,32,34)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 28n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347475
PNG
(US9790180, ID 009)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)C(=O)N2CCCCC2)nc1)-c1cccs1
Show InChI InChI=1S/C26H31N7O2S/c27-21-7-6-18(23-5-4-14-36-23)15-22(21)31-24(34)19-16-28-25(29-17-19)30-20-8-12-33(13-9-20)26(35)32-10-2-1-3-11-32/h4-7,14-17,20H,1-3,8-13,27H2,(H,31,34)(H,28,29,30)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 32n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347477
PNG
(US9790180, ID 011)
Show SMILES CN1CCN(CC1)C(=O)N1CCC(C)(CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C27H34N8O2S/c1-27(7-9-34(10-8-27)26(37)35-13-11-33(2)12-14-35)32-25-29-17-20(18-30-25)24(36)31-22-16-19(5-6-21(22)28)23-4-3-15-38-23/h3-6,15-18H,7-14,28H2,1-2H3,(H,31,36)(H,29,30,32)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 32n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347474
PNG
(US9790180, ID 008)
Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C26H31N7O3S/c1-26(6-8-32(9-7-26)25(35)33-10-12-36-13-11-33)31-24-28-16-19(17-29-24)23(34)30-21-15-18(4-5-20(21)27)22-3-2-14-37-22/h2-5,14-17H,6-13,27H2,1H3,(H,30,34)(H,28,29,31)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 37n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347455
PNG
(US9790180, ID 001)
Show SMILES CC(C)NC(=O)N1CCC(C)(CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C25H31N7O2S/c1-16(2)29-24(34)32-10-8-25(3,9-11-32)31-23-27-14-18(15-28-23)22(33)30-20-13-17(6-7-19(20)26)21-5-4-12-35-21/h4-7,12-16H,8-11,26H2,1-3H3,(H,29,34)(H,30,33)(H,27,28,31)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 38n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347508
PNG
(US9790180, ID 040)
Show SMILES CN1CCC(CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C23H26N6O/c1-29-11-9-19(10-12-29)27-23-25-14-18(15-26-23)22(30)28-21-13-17(7-8-20(21)24)16-5-3-2-4-6-16/h2-8,13-15,19H,9-12,24H2,1H3,(H,28,30)(H,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 39n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347485
PNG
(US9790180, ID 019 | US9790180, ID 020)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCOCC2)cc1)-c1cccs1
Show InChI InChI=1S/C27H31N5O3S/c28-23-8-5-20(25-2-1-17-36-25)18-24(23)30-26(33)19-3-6-21(7-4-19)29-22-9-11-31(12-10-22)27(34)32-13-15-35-16-14-32/h1-8,17-18,22,29H,9-16,28H2,(H,30,33)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 43n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347501
PNG
(US9790180, ID 033)
Show SMILES CN(C1CCN(CC1)C(=O)Cc1c[nH]c2ccccc12)c1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C33H33N7O2/c1-39(26-13-15-40(16-14-26)31(41)18-24-19-35-29-10-6-5-9-27(24)29)33-36-20-25(21-37-33)32(42)38-30-17-23(11-12-28(30)34)22-7-3-2-4-8-22/h2-12,17,19-21,26,35H,13-16,18,34H2,1H3,(H,38,42)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 48n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347467
PNG
(US9790180, ID 003)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)C(=O)N2CCOCC2)nc1)-c1cccs1
Show InChI InChI=1S/C25H29N7O3S/c26-20-4-3-17(22-2-1-13-36-22)14-21(20)30-23(33)18-15-27-24(28-16-18)29-19-5-7-31(8-6-19)25(34)32-9-11-35-12-10-32/h1-4,13-16,19H,5-12,26H2,(H,30,33)(H,27,28,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 56n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347507
PNG
(US9790180, ID 039)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCNCC2)nc1)-c1ccccc1
Show InChI InChI=1S/C22H24N6O/c23-19-7-6-16(15-4-2-1-3-5-15)12-20(19)28-21(29)17-13-25-22(26-14-17)27-18-8-10-24-11-9-18/h1-7,12-14,18,24H,8-11,23H2,(H,28,29)(H,25,26,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 59n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347480
PNG
(US9790180, ID 014)
Show SMILES CC1(CCN(CC1)C(=O)N1CCC(O)CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C27H33N7O3S/c1-27(8-12-34(13-9-27)26(37)33-10-6-20(35)7-11-33)32-25-29-16-19(17-30-25)24(36)31-22-15-18(4-5-21(22)28)23-3-2-14-38-23/h2-5,14-17,20,35H,6-13,28H2,1H3,(H,31,36)(H,29,30,32)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 63n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347498
PNG
(US9790180, ID 031)
Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccnc1
Show InChI InChI=1S/C29H34N6O3/c1-29(10-13-34(14-11-29)28(37)35-15-17-38-18-16-35)33-24-7-4-21(5-8-24)27(36)32-26-19-22(6-9-25(26)30)23-3-2-12-31-20-23/h2-9,12,19-20,33H,10-11,13-18,30H2,1H3,(H,32,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 71n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347493
PNG
(US9790180, ID 026)
Show SMILES CN1CCC(CC1)(Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1)c1ccccc1
Show InChI InChI=1S/C27H28N6OS/c1-33-13-11-27(12-14-33,21-6-3-2-4-7-21)32-26-29-17-20(18-30-26)25(34)31-23-16-19(9-10-22(23)28)24-8-5-15-35-24/h2-10,15-18H,11-14,28H2,1H3,(H,31,34)(H,29,30,32)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 72n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347488
PNG
(US9790180, ID 021)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2CCCCC2)cc1)-c1cccs1
Show InChI InChI=1S/C29H34N4O2S/c30-25-13-10-22(27-7-4-18-36-27)19-26(25)32-28(34)20-8-11-23(12-9-20)31-24-14-16-33(17-15-24)29(35)21-5-2-1-3-6-21/h4,7-13,18-19,21,24,31H,1-3,5-6,14-17,30H2,(H,32,34)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 72n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347495
PNG
(US9790180, ID 028)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)c2ccccc2)cc1)-c1cccs1
Show InChI InChI=1S/C28H28N4OS/c29-25-13-10-21(27-7-4-18-34-27)19-26(25)31-28(33)20-8-11-22(12-9-20)30-23-14-16-32(17-15-23)24-5-2-1-3-6-24/h1-13,18-19,23,30H,14-17,29H2,(H,31,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 74n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347504
PNG
(US9790180, ID 036)
Show SMILES Cc1[nH]c2ccccc2c1CC(=O)N1CCC(CC1)N(c1ccccc1)c1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C39H37N7O2/c1-26-33(32-14-8-9-15-35(32)43-26)23-37(47)45-20-18-31(19-21-45)46(30-12-6-3-7-13-30)39-41-24-29(25-42-39)38(48)44-36-22-28(16-17-34(36)40)27-10-4-2-5-11-27/h2-17,22,24-25,31,43H,18-21,23,40H2,1H3,(H,44,48)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 74n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347484
PNG
(US9790180, ID 018)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(nc1)N1CCCC11CCN(CC1)C(=O)N1CCCC1)-c1cccs1
Show InChI InChI=1S/C28H33N7O2S/c29-22-7-6-20(24-5-3-16-38-24)17-23(22)32-25(36)21-18-30-26(31-19-21)35-13-4-8-28(35)9-14-34(15-10-28)27(37)33-11-1-2-12-33/h3,5-7,16-19H,1-2,4,8-15,29H2,(H,32,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 78n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347471
PNG
(US9790180, ID 005)
Show SMILES CN1CCN(CC1)C(=O)N1CCC(CC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C28H34N6O2S/c1-32-14-16-34(17-15-32)28(36)33-12-10-23(11-13-33)30-22-7-4-20(5-8-22)27(35)31-25-19-21(6-9-24(25)29)26-3-2-18-37-26/h2-9,18-19,23,30H,10-17,29H2,1H3,(H,31,35)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 82n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347498
PNG
(US9790180, ID 031)
Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccnc1
Show InChI InChI=1S/C29H34N6O3/c1-29(10-13-34(14-11-29)28(37)35-15-17-38-18-16-35)33-24-7-4-21(5-8-24)27(36)32-26-19-22(6-9-25(26)30)23-3-2-12-31-20-23/h2-9,12,19-20,33H,10-11,13-18,30H2,1H3,(H,32,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 91n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347502
PNG
(US9790180, ID 034)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(nc1)N(C1CCN(CC1)C(=O)Cc1c[nH]c2ccccc12)c1ccccc1)-c1ccccc1
Show InChI InChI=1S/C38H35N7O2/c39-33-16-15-27(26-9-3-1-4-10-26)21-35(33)43-37(47)29-24-41-38(42-25-29)45(30-11-5-2-6-12-30)31-17-19-44(20-18-31)36(46)22-28-23-40-34-14-8-7-13-32(28)34/h1-16,21,23-25,31,40H,17-20,22,39H2,(H,43,47)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 93n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347483
PNG
(US9790180, ID 017)
Show SMILES CCC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C29H35N5O3S/c1-2-29(11-13-33(14-12-29)28(36)34-15-17-37-18-16-34)32-23-8-5-21(6-9-23)27(35)31-25-20-22(7-10-24(25)30)26-4-3-19-38-26/h3-10,19-20,32H,2,11-18,30H2,1H3,(H,31,35)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 99n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347506
PNG
(US9790180, ID 038)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCNc3ccccc23)nc1)-c1ccccc1
Show InChI InChI=1S/C26H24N6O/c27-21-11-10-18(17-6-2-1-3-7-17)14-24(21)31-25(33)19-15-29-26(30-16-19)32-23-12-13-28-22-9-5-4-8-20(22)23/h1-11,14-16,23,28H,12-13,27H2,(H,31,33)(H,29,30,32)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 101n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347473
PNG
(US9790180, ID 007)
Show SMILES CC1(CCN(CC1)C(=O)Oc1ccccc1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C28H28N6O3S/c1-28(11-13-34(14-12-28)27(36)37-21-6-3-2-4-7-21)33-26-30-17-20(18-31-26)25(35)32-23-16-19(9-10-22(23)29)24-8-5-15-38-24/h2-10,15-18H,11-14,29H2,1H3,(H,32,35)(H,30,31,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 118n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347494
PNG
(US9790180, ID 027)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)c2ccccc2)nc1)-c1cccs1
Show InChI InChI=1S/C26H26N6OS/c27-22-9-8-18(24-7-4-14-34-24)15-23(22)31-25(33)19-16-28-26(29-17-19)30-20-10-12-32(13-11-20)21-5-2-1-3-6-21/h1-9,14-17,20H,10-13,27H2,(H,31,33)(H,28,29,30)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 121n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347474
PNG
(US9790180, ID 008)
Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C26H31N7O3S/c1-26(6-8-32(9-7-26)25(35)33-10-12-36-13-11-33)31-24-28-16-19(17-29-24)23(34)30-21-15-18(4-5-20(21)27)22-3-2-14-37-22/h2-5,14-17H,6-13,27H2,1H3,(H,30,34)(H,28,29,31)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 124n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347482
PNG
(US9790180, ID 016)
Show SMILES CN1CCN(CC1)C(=O)N1CCC(C)(CC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C29H36N6O2S/c1-29(11-13-34(14-12-29)28(37)35-17-15-33(2)16-18-35)32-23-8-5-21(6-9-23)27(36)31-25-20-22(7-10-24(25)30)26-4-3-19-38-26/h3-10,19-20,32H,11-18,30H2,1-2H3,(H,31,36)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 145n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347475
PNG
(US9790180, ID 009)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)C(=O)N2CCCCC2)nc1)-c1cccs1
Show InChI InChI=1S/C26H31N7O2S/c27-21-7-6-18(23-5-4-14-36-23)15-22(21)31-24(34)19-16-28-25(29-17-19)30-20-8-12-33(13-9-20)26(35)32-10-2-1-3-11-32/h4-7,14-17,20H,1-3,8-13,27H2,(H,31,34)(H,28,29,30)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 145n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347481
PNG
(US9790180, ID 015)
Show SMILES CC1(CCN(CC1)C(=O)N1CCNCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C28H34N6O2S/c1-28(10-14-33(15-11-28)27(36)34-16-12-30-13-17-34)32-22-7-4-20(5-8-22)26(35)31-24-19-21(6-9-23(24)29)25-3-2-18-37-25/h2-9,18-19,30,32H,10-17,29H2,1H3,(H,31,35)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 149n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347478
PNG
(US9790180, ID 012)
Show SMILES CC1(CCN(CC1)C(=O)N1CCC(F)(F)CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C27H31F2N7O2S/c1-26(6-10-35(11-7-26)25(38)36-12-8-27(28,29)9-13-36)34-24-31-16-19(17-32-24)23(37)33-21-15-18(4-5-20(21)30)22-3-2-14-39-22/h2-5,14-17H,6-13,30H2,1H3,(H,33,37)(H,31,32,34)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 177n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347476
PNG
(US9790180, ID 010)
Show SMILES CC1(CCN(CC1)C(=O)N1CCNCC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C26H32N8O2S/c1-26(6-10-33(11-7-26)25(36)34-12-8-28-9-13-34)32-24-29-16-19(17-30-24)23(35)31-21-15-18(4-5-20(21)27)22-3-2-14-37-22/h2-5,14-17,28H,6-13,27H2,1H3,(H,31,35)(H,29,30,32)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 195n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347503
PNG
(US9790180, ID 035)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)C(=O)Cc2c[nH]c3ccccc23)nc1)-c1ccccc1
Show InChI InChI=1S/C32H31N7O2/c33-27-11-10-22(21-6-2-1-3-7-21)16-29(27)38-31(41)24-19-35-32(36-20-24)37-25-12-14-39(15-13-25)30(40)17-23-18-34-28-9-5-4-8-26(23)28/h1-11,16,18-20,25,34H,12-15,17,33H2,(H,38,41)(H,35,36,37)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 196n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347477
PNG
(US9790180, ID 011)
Show SMILES CN1CCN(CC1)C(=O)N1CCC(C)(CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C27H34N8O2S/c1-27(7-9-34(10-8-27)26(37)35-13-11-33(2)12-14-35)32-25-29-17-20(18-30-25)24(36)31-22-16-19(5-6-21(22)28)23-4-3-15-38-23/h3-6,15-18H,7-14,28H2,1-2H3,(H,31,36)(H,29,30,32)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 201n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347489
PNG
(US9790180, ID 022)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2CCOCC2)cc1)-c1cccs1
Show InChI InChI=1S/C28H32N4O3S/c29-24-8-5-21(26-2-1-17-36-26)18-25(24)31-27(33)19-3-6-22(7-4-19)30-23-9-13-32(14-10-23)28(34)20-11-15-35-16-12-20/h1-8,17-18,20,23,30H,9-16,29H2,(H,31,33)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 203n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347459
PNG
(US9790180, ID 002)
Show SMILES CC(C)C1(CCN(CC1)C(=O)N1CCN(C)CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C29H38N8O2S/c1-20(2)29(8-10-36(11-9-29)28(39)37-14-12-35(3)13-15-37)34-27-31-18-22(19-32-27)26(38)33-24-17-21(6-7-23(24)30)25-5-4-16-40-25/h4-7,16-20H,8-15,30H2,1-3H3,(H,33,38)(H,31,32,34)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 203n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347467
PNG
(US9790180, ID 003)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)C(=O)N2CCOCC2)nc1)-c1cccs1
Show InChI InChI=1S/C25H29N7O3S/c26-20-4-3-17(22-2-1-13-36-22)14-21(20)30-23(33)18-15-27-24(28-16-18)29-19-5-7-31(8-6-19)25(34)32-9-11-35-12-10-32/h1-4,13-16,19H,5-12,26H2,(H,30,33)(H,27,28,29)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 204n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347510
PNG
(US9790180, ID 042)
Show SMILES CN1CCC(Nc2ncc(cn2)C(=O)Nc2cc(ccc2N)-c2ccccc2)c2ccccc12
Show InChI InChI=1S/C27H26N6O/c1-33-14-13-23(21-9-5-6-10-25(21)33)32-27-29-16-20(17-30-27)26(34)31-24-15-19(11-12-22(24)28)18-7-3-2-4-8-18/h2-12,15-17,23H,13-14,28H2,1H3,(H,31,34)(H,29,30,32)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 210n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347501
PNG
(US9790180, ID 033)
Show SMILES CN(C1CCN(CC1)C(=O)Cc1c[nH]c2ccccc12)c1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C33H33N7O2/c1-39(26-13-15-40(16-14-26)31(41)18-24-19-35-29-10-6-5-9-27(24)29)33-36-20-25(21-37-33)32(42)38-30-17-23(11-12-28(30)34)22-7-3-2-4-8-22/h2-12,17,19-21,26,35H,13-16,18,34H2,1H3,(H,38,42)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 211n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347475
PNG
(US9790180, ID 009)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)C(=O)N2CCCCC2)nc1)-c1cccs1
Show InChI InChI=1S/C26H31N7O2S/c27-21-7-6-18(23-5-4-14-36-23)15-22(21)31-24(34)19-16-28-25(29-17-19)30-20-8-12-33(13-9-20)26(35)32-10-2-1-3-11-32/h4-7,14-17,20H,1-3,8-13,27H2,(H,31,34)(H,28,29,30)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 250n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347509
PNG
(US9790180, ID 041)
Show SMILES CC1(CCNCC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C23H26N6O/c1-23(9-11-25-12-10-23)29-22-26-14-18(15-27-22)21(30)28-20-13-17(7-8-19(20)24)16-5-3-2-4-6-16/h2-8,13-15,25H,9-12,24H2,1H3,(H,28,30)(H,26,27,29)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 252n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347498
PNG
(US9790180, ID 031)
Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccnc1
Show InChI InChI=1S/C29H34N6O3/c1-29(10-13-34(14-11-29)28(37)35-15-17-38-18-16-35)33-24-7-4-21(5-8-24)27(36)32-26-19-22(6-9-25(26)30)23-3-2-12-31-20-23/h2-9,12,19-20,33H,10-11,13-18,30H2,1H3,(H,32,36)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 264n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347490
PNG
(US9790180, ID 023)
Show SMILES CCC1(CCN(CC1)C(=O)N1CCNCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C29H36N6O2S/c1-2-29(11-15-34(16-12-29)28(37)35-17-13-31-14-18-35)33-23-8-5-21(6-9-23)27(36)32-25-20-22(7-10-24(25)30)26-4-3-19-38-26/h3-10,19-20,31,33H,2,11-18,30H2,1H3,(H,32,36)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 267n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347472
PNG
(US9790180, ID 006)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCCC2)cc1)-c1cccs1
Show InChI InChI=1S/C27H31N5O2S/c28-23-10-7-20(25-4-3-17-35-25)18-24(23)30-26(33)19-5-8-21(9-6-19)29-22-11-15-32(16-12-22)27(34)31-13-1-2-14-31/h3-10,17-18,22,29H,1-2,11-16,28H2,(H,30,33)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 274n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347508
PNG
(US9790180, ID 040)
Show SMILES CN1CCC(CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C23H26N6O/c1-29-11-9-19(10-12-29)27-23-25-14-18(15-26-23)22(30)28-21-13-17(7-8-20(21)24)16-5-3-2-4-6-16/h2-8,13-15,19H,9-12,24H2,1H3,(H,28,30)(H,25,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 277n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347468
PNG
(US9790180, ID 004)
Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C28H33N5O3S/c1-28(10-12-32(13-11-28)27(35)33-14-16-36-17-15-33)31-22-7-4-20(5-8-22)26(34)30-24-19-21(6-9-23(24)29)25-3-2-18-37-25/h2-9,18-19,31H,10-17,29H2,1H3,(H,30,34)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 286n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347491
PNG
(US9790180, ID 024)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2(O)CCCCC2)cc1)-c1cccs1
Show InChI InChI=1S/C29H34N4O3S/c30-24-11-8-21(26-5-4-18-37-26)19-25(24)32-27(34)20-6-9-22(10-7-20)31-23-12-16-33(17-13-23)28(35)29(36)14-2-1-3-15-29/h4-11,18-19,23,31,36H,1-3,12-17,30H2,(H,32,34)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 287n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347480
PNG
(US9790180, ID 014)
Show SMILES CC1(CCN(CC1)C(=O)N1CCC(O)CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C27H33N7O3S/c1-27(8-12-34(13-9-27)26(37)33-10-6-20(35)7-11-33)32-25-29-16-19(17-30-25)24(36)31-22-15-18(4-5-21(22)28)23-3-2-14-38-23/h2-5,14-17,20,35H,6-13,28H2,1H3,(H,31,36)(H,29,30,32)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 299n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347485
PNG
(US9790180, ID 019 | US9790180, ID 020)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCOCC2)cc1)-c1cccs1
Show InChI InChI=1S/C27H31N5O3S/c28-23-8-5-20(25-2-1-17-36-25)18-24(23)30-26(33)19-3-6-21(7-4-19)29-22-9-11-31(12-10-22)27(34)32-13-15-35-16-14-32/h1-8,17-18,22,29H,9-16,28H2,(H,30,33)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 304n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347493
PNG
(US9790180, ID 026)
Show SMILES CN1CCC(CC1)(Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1)c1ccccc1
Show InChI InChI=1S/C27H28N6OS/c1-33-13-11-27(12-14-33,21-6-3-2-4-7-21)32-26-29-17-20(18-30-26)25(34)31-23-16-19(9-10-22(23)28)24-8-5-15-35-24/h2-10,15-18H,11-14,28H2,1H3,(H,31,34)(H,29,30,32)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 315n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347506
PNG
(US9790180, ID 038)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCNc3ccccc23)nc1)-c1ccccc1
Show InChI InChI=1S/C26H24N6O/c27-21-11-10-18(17-6-2-1-3-7-17)14-24(21)31-25(33)19-15-29-26(30-16-19)32-23-12-13-28-22-9-5-4-8-20(22)23/h1-11,14-16,23,28H,12-13,27H2,(H,31,33)(H,29,30,32)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 319n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347507
PNG
(US9790180, ID 039)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCNCC2)nc1)-c1ccccc1
Show InChI InChI=1S/C22H24N6O/c23-19-7-6-16(15-4-2-1-3-5-15)12-20(19)28-21(29)17-13-25-22(26-14-17)27-18-8-10-24-11-9-18/h1-7,12-14,18,24H,8-11,23H2,(H,28,29)(H,25,26,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 321n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347502
PNG
(US9790180, ID 034)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(nc1)N(C1CCN(CC1)C(=O)Cc1c[nH]c2ccccc12)c1ccccc1)-c1ccccc1
Show InChI InChI=1S/C38H35N7O2/c39-33-16-15-27(26-9-3-1-4-10-26)21-35(33)43-37(47)29-24-41-38(42-25-29)45(30-11-5-2-6-12-30)31-17-19-44(20-18-31)36(46)22-28-23-40-34-14-8-7-13-32(28)34/h1-16,21,23-25,31,40H,17-20,22,39H2,(H,43,47)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 346n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347492
PNG
(US9790180, ID 025)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2(O)CCCC2)cc1)-c1cccs1
Show InChI InChI=1S/C28H32N4O3S/c29-23-10-7-20(25-4-3-17-36-25)18-24(23)31-26(33)19-5-8-21(9-6-19)30-22-11-15-32(16-12-22)27(34)28(35)13-1-2-14-28/h3-10,17-18,22,30,35H,1-2,11-16,29H2,(H,31,33)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 355n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347505
PNG
(US9790180, ID 037)
Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1C1CC1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C33H39N5O3/c1-33(13-15-37(16-14-33)32(40)38-17-19-41-20-18-38)36-29-12-10-26(21-27(29)24-7-8-24)31(39)35-30-22-25(9-11-28(30)34)23-5-3-2-4-6-23/h2-6,9-12,21-22,24,36H,7-8,13-20,34H2,1H3,(H,35,39)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 377n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347500
PNG
(US9790180, ID 032)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)N2CCCC2)cc1)-c1ccncc1
Show InChI InChI=1S/C28H32N6O2/c29-25-8-5-22(20-9-13-30-14-10-20)19-26(25)32-27(35)21-3-6-23(7-4-21)31-24-11-17-34(18-12-24)28(36)33-15-1-2-16-33/h3-10,13-14,19,24,31H,1-2,11-12,15-18,29H2,(H,32,35)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 397n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347479
PNG
(US9790180, ID 013)
Show SMILES CC1(CCN(CC1)C(=O)N1CCCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C28H33N5O2S/c1-28(12-16-33(17-13-28)27(35)32-14-2-3-15-32)31-22-9-6-20(7-10-22)26(34)30-24-19-21(8-11-23(24)29)25-5-4-18-36-25/h4-11,18-19,31H,2-3,12-17,29H2,1H3,(H,30,34)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 412n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347455
PNG
(US9790180, ID 001)
Show SMILES CC(C)NC(=O)N1CCC(C)(CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C25H31N7O2S/c1-16(2)29-24(34)32-10-8-25(3,9-11-32)31-23-27-14-18(15-28-23)22(33)30-20-13-17(6-7-19(20)26)21-5-4-12-35-21/h4-7,12-16H,8-11,26H2,1-3H3,(H,29,34)(H,30,33)(H,27,28,31)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 427n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM347505
PNG
(US9790180, ID 037)
Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1C1CC1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C33H39N5O3/c1-33(13-15-37(16-14-33)32(40)38-17-19-41-20-18-38)36-29-12-10-26(21-27(29)24-7-8-24)31(39)35-30-22-25(9-11-28(30)34)23-5-3-2-4-6-23/h2-6,9-12,21-22,24,36H,7-8,13-20,34H2,1H3,(H,35,39)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 432n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were...


US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347495
PNG
(US9790180, ID 028)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)c2ccccc2)cc1)-c1cccs1
Show InChI InChI=1S/C28H28N4OS/c29-25-13-10-21(27-7-4-18-34-27)19-26(25)31-28(33)20-8-11-22(12-9-20)30-23-14-16-32(17-15-23)24-5-2-1-3-6-24/h1-13,18-19,23,30H,14-17,29H2,(H,31,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 443n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347497
PNG
(US9790180, ID 030)
Show SMILES CC1(CCN(CC1)C(=O)N1CCCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1ccncc1
Show InChI InChI=1S/C29H34N6O2/c1-29(12-18-35(19-13-29)28(37)34-16-2-3-17-34)33-24-7-4-22(5-8-24)27(36)32-26-20-23(6-9-25(26)30)21-10-14-31-15-11-21/h4-11,14-15,20,33H,2-3,12-13,16-19,30H2,1H3,(H,32,36)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 466n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347484
PNG
(US9790180, ID 018)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(nc1)N1CCCC11CCN(CC1)C(=O)N1CCCC1)-c1cccs1
Show InChI InChI=1S/C28H33N7O2S/c29-22-7-6-20(24-5-3-16-38-24)17-23(22)32-25(36)21-18-30-26(31-19-21)35-13-4-8-28(35)9-14-34(15-10-28)27(37)33-11-1-2-12-33/h3,5-7,16-19H,1-2,4,8-15,29H2,(H,32,36)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 516n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347496
PNG
(US9790180, ID 029)
Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1ccncc1
Show InChI InChI=1S/C29H34N6O3/c1-29(10-14-34(15-11-29)28(37)35-16-18-38-19-17-35)33-24-5-2-22(3-6-24)27(36)32-26-20-23(4-7-25(26)30)21-8-12-31-13-9-21/h2-9,12-13,20,33H,10-11,14-19,30H2,1H3,(H,32,36)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 541n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347488
PNG
(US9790180, ID 021)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2CCCCC2)cc1)-c1cccs1
Show InChI InChI=1S/C29H34N4O2S/c30-25-13-10-22(27-7-4-18-36-27)19-26(25)32-28(34)20-8-11-23(12-9-20)31-24-14-16-33(17-15-24)29(35)21-5-2-1-3-6-21/h4,7-13,18-19,21,24,31H,1-3,5-6,14-17,30H2,(H,32,34)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 555n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347494
PNG
(US9790180, ID 027)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)c2ccccc2)nc1)-c1cccs1
Show InChI InChI=1S/C26H26N6OS/c27-22-9-8-18(24-7-4-14-34-24)15-23(22)31-25(33)19-16-28-26(29-17-19)30-20-10-12-32(13-11-20)21-5-2-1-3-6-21/h1-9,14-17,20H,10-13,27H2,(H,31,33)(H,28,29,30)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 690n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347473
PNG
(US9790180, ID 007)
Show SMILES CC1(CCN(CC1)C(=O)Oc1ccccc1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C28H28N6O3S/c1-28(11-13-34(14-12-28)27(36)37-21-6-3-2-4-7-21)33-26-30-17-20(18-31-26)25(35)32-23-16-19(9-10-22(23)29)24-8-5-15-38-24/h2-10,15-18H,11-14,29H2,1H3,(H,32,35)(H,30,31,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 703n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347510
PNG
(US9790180, ID 042)
Show SMILES CN1CCC(Nc2ncc(cn2)C(=O)Nc2cc(ccc2N)-c2ccccc2)c2ccccc12
Show InChI InChI=1S/C27H26N6O/c1-33-14-13-23(21-9-5-6-10-25(21)33)32-27-29-16-20(17-30-27)26(34)31-24-15-19(11-12-22(24)28)18-7-3-2-4-8-18/h2-12,15-17,23H,13-14,28H2,1H3,(H,31,34)(H,29,30,32)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 714n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347473
PNG
(US9790180, ID 007)
Show SMILES CC1(CCN(CC1)C(=O)Oc1ccccc1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C28H28N6O3S/c1-28(11-13-34(14-12-28)27(36)37-21-6-3-2-4-7-21)33-26-30-17-20(18-31-26)25(35)32-23-16-19(9-10-22(23)29)24-8-5-15-38-24/h2-10,15-18H,11-14,29H2,1H3,(H,32,35)(H,30,31,33)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 929n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM347504
PNG
(US9790180, ID 036)
Show SMILES Cc1[nH]c2ccccc2c1CC(=O)N1CCC(CC1)N(c1ccccc1)c1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C39H37N7O2/c1-26-33(32-14-8-9-15-35(32)43-26)23-37(47)45-20-18-31(19-21-45)46(30-12-6-3-7-13-30)39-41-24-29(25-42-39)38(48)44-36-22-28(16-17-34(36)40)27-10-4-2-5-11-27/h2-17,22,24-25,31,43H,18-21,23,40H2,1H3,(H,44,48)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 996n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347478
PNG
(US9790180, ID 012)
Show SMILES CC1(CCN(CC1)C(=O)N1CCC(F)(F)CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C27H31F2N7O2S/c1-26(6-10-35(11-7-26)25(38)36-12-8-27(28,29)9-13-36)34-24-31-16-19(17-32-24)23(37)33-21-15-18(4-5-20(21)30)22-3-2-14-39-22/h2-5,14-17H,6-13,30H2,1H3,(H,33,37)(H,31,32,34)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.27E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347503
PNG
(US9790180, ID 035)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)C(=O)Cc2c[nH]c3ccccc23)nc1)-c1ccccc1
Show InChI InChI=1S/C32H31N7O2/c33-27-11-10-22(21-6-2-1-3-7-21)16-29(27)38-31(41)24-19-35-32(36-20-24)37-25-12-14-39(15-13-25)30(40)17-23-18-34-28-9-5-4-8-26(23)28/h1-11,16,18-20,25,34H,12-15,17,33H2,(H,38,41)(H,35,36,37)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.40E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347483
PNG
(US9790180, ID 017)
Show SMILES CCC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C29H35N5O3S/c1-2-29(11-13-33(14-12-29)28(36)34-15-17-37-18-16-34)32-23-8-5-21(6-9-23)27(35)31-25-20-22(7-10-24(25)30)26-4-3-19-38-26/h3-10,19-20,32H,2,11-18,30H2,1H3,(H,31,35)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.74E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347505
PNG
(US9790180, ID 037)
Show SMILES CC1(CCN(CC1)C(=O)N1CCOCC1)Nc1ccc(cc1C1CC1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C33H39N5O3/c1-33(13-15-37(16-14-33)32(40)38-17-19-41-20-18-38)36-29-12-10-26(21-27(29)24-7-8-24)31(39)35-30-22-25(9-11-28(30)34)23-5-3-2-4-6-23/h2-6,9-12,21-22,24,36H,7-8,13-20,34H2,1H3,(H,35,39)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 1.86E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347510
PNG
(US9790180, ID 042)
Show SMILES CN1CCC(Nc2ncc(cn2)C(=O)Nc2cc(ccc2N)-c2ccccc2)c2ccccc12
Show InChI InChI=1S/C27H26N6O/c1-33-14-13-23(21-9-5-6-10-25(21)33)32-27-29-16-20(17-30-27)26(34)31-24-15-19(11-12-22(24)28)18-7-3-2-4-8-18/h2-12,15-17,23H,13-14,28H2,1H3,(H,31,34)(H,29,30,32)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>2.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347495
PNG
(US9790180, ID 028)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)c2ccccc2)cc1)-c1cccs1
Show InChI InChI=1S/C28H28N4OS/c29-25-13-10-21(27-7-4-18-34-27)19-26(25)31-28(33)20-8-11-22(12-9-20)30-23-14-16-32(17-15-23)24-5-2-1-3-6-24/h1-13,18-19,23,30H,14-17,29H2,(H,31,33)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>2.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347506
PNG
(US9790180, ID 038)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCNc3ccccc23)nc1)-c1ccccc1
Show InChI InChI=1S/C26H24N6O/c27-21-11-10-18(17-6-2-1-3-7-17)14-24(21)31-25(33)19-15-29-26(30-16-19)32-23-12-13-28-22-9-5-4-8-20(22)23/h1-11,14-16,23,28H,12-13,27H2,(H,31,33)(H,29,30,32)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>2.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347504
PNG
(US9790180, ID 036)
Show SMILES Cc1[nH]c2ccccc2c1CC(=O)N1CCC(CC1)N(c1ccccc1)c1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C39H37N7O2/c1-26-33(32-14-8-9-15-35(32)43-26)23-37(47)45-20-18-31(19-21-45)46(30-12-6-3-7-13-30)39-41-24-29(25-42-39)38(48)44-36-22-28(16-17-34(36)40)27-10-4-2-5-11-27/h2-17,22,24-25,31,43H,18-21,23,40H2,1H3,(H,44,48)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>2.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347494
PNG
(US9790180, ID 027)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(NC2CCN(CC2)c2ccccc2)nc1)-c1cccs1
Show InChI InChI=1S/C26H26N6OS/c27-22-9-8-18(24-7-4-14-34-24)15-23(22)31-25(33)19-16-28-26(29-17-19)30-20-10-12-32(13-11-20)21-5-2-1-3-6-21/h1-9,14-17,20H,10-13,27H2,(H,31,33)(H,28,29,30)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>2.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347480
PNG
(US9790180, ID 014)
Show SMILES CC1(CCN(CC1)C(=O)N1CCC(O)CC1)Nc1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C27H33N7O3S/c1-27(8-12-34(13-9-27)26(37)33-10-6-20(35)7-11-33)32-25-29-16-19(17-30-25)24(36)31-22-15-18(4-5-21(22)28)23-3-2-14-38-23/h2-5,14-17,20,35H,6-13,28H2,1H3,(H,31,36)(H,29,30,32)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>2.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347502
PNG
(US9790180, ID 034)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(nc1)N(C1CCN(CC1)C(=O)Cc1c[nH]c2ccccc12)c1ccccc1)-c1ccccc1
Show InChI InChI=1S/C38H35N7O2/c39-33-16-15-27(26-9-3-1-4-10-26)21-35(33)43-37(47)29-24-41-38(42-25-29)45(30-11-5-2-6-12-30)31-17-19-44(20-18-31)36(46)22-28-23-40-34-14-8-7-13-32(28)34/h1-16,21,23-25,31,40H,17-20,22,39H2,(H,43,47)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>2.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM347501
PNG
(US9790180, ID 033)
Show SMILES CN(C1CCN(CC1)C(=O)Cc1c[nH]c2ccccc12)c1ncc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C33H33N7O2/c1-39(26-13-15-40(16-14-26)31(41)18-24-19-35-29-10-6-5-9-27(24)29)33-36-20-25(21-37-33)32(42)38-30-17-23(11-12-28(30)34)22-7-3-2-4-8-22/h2-12,17,19-21,26,35H,13-16,18,34H2,1H3,(H,38,42)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>2.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent




US Patent US9790180 (2017)

More data for this
Ligand-Target Pair
* indicates data uncertainty>20%